Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumor cell lysis by cytotoxic T-cells

This publication has 9 references indexed in Scilit:

• Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity
  International Journal of Cancer, 1987
• The use of hybrid hybridomas to target human cytotoxic T lymphocytes
  European Journal of Immunology, 1987
• MONOCLONAL ANTIBODIES IN CANCER TREATMENT
  The Lancet, 1986
• Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.
  Proceedings of the National Academy of Sciences, 1986
• Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.
  The Journal of Experimental Medicine, 1986
• Ricin A Chain Conjugated With Monoclonal Antibodies Selectively Killing Human Carcinoma Cells In Vitro2
  JNCI Journal of the National Cancer Institute, 1985
• Hybrid hybridomas and the production of bi-specific monoclonal antibodies
  Immunology Today, 1984
• On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.
  The Journal of Immunology, 1983
• Continuous cultures of fused cells secreting antibody of predefined specificity
  Nature, 1975